Exploring DCCR as an Important Therapeutic Option for PWS
Time: 5:20 pm
day: Day Two
Details:
- Elucidating the mechanism of action for the DCCR development program for PWS
- Evaluating the dose rationale for future studies
- Regulatory back and forth for advancing phase 3 program, outcomes and key learnings
